IRONWOOD PHARMACEUTICALS INC (IRWD)

Latest Insider Confidence Score

2026Q1

48.2
Bearish

Company insider confidence (by quarter)

2014Q1 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Denner Alexander J Director 16,390,000 Sep 18, 2024
Sarissa Capital Management LP Director 16,390,000 Sep 18, 2024
MCCOURT Thomas A CEO 1,687,281 May 20, 2025
Hecht Peter M CEO 690,000 Apr 3, 2019
Currie Mark G Director 613,419 Jun 12, 2025

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 23, 2026 Feb 25, 2026 John Minardo Chief Legal Officer Sell 42.5 -36,492 -9.11% ✗ $136.2K
Feb 23, 2026 Feb 25, 2026 Shetzline Michael SVP, CMO, Head-Res&Drug Buy 55.0 +1,442 0.14% ✗ $2.9K
Feb 23, 2026 Feb 25, 2026 Gaskins Tammi L Chief Commercial Officer Sell 42.5 -21,526 -9.15% ✗ $80.3K
Feb 23, 2026 Feb 25, 2026 MCCOURT Thomas A CEO Sell 40.0 -198,283 -11.75% ✗ $739.9K
Feb 23, 2026 Feb 25, 2026 Martini Gregory S. CFO Sell 42.5 -21,944 -12.02% ✗ $81.9K
Feb 23, 2026 Feb 25, 2026 Silver Ronald Principal Accounting Officer Sell 42.5 -24,173 -8.73% ✗ $90.2K
Jan 5, 2026 Jan 7, 2026 Silver Ronald Principal Accounting Officer Sell 26.3 -35,416 -11.34% ✓ $162.9K
Dec 15, 2025 Dec 17, 2025 DENNER ALEXANDER J Director Neutral 47.5 +4,178 0.03% ✗ -
Nov 17, 2025 Nov 19, 2025 Gaskins Tammi L Chief Commercial Officer Sell 46.3 -6,016 -2.49% ✗ $20K
Sep 15, 2025 Sep 17, 2025 DENNER ALEXANDER J Director Neutral 55.0 +11,718 0.07% ✗ -
Aug 11, 2025 Aug 13, 2025 Gaskins Tammi L Chief Commercial Officer Sell 50.0 -1,316 -0.54% ✗ $1.1K
Aug 11, 2025 Aug 13, 2025 John Minardo Chief Legal Officer Sell 47.5 -7,754 -1.90% ✗ $6.5K
Aug 11, 2025 Aug 13, 2025 Martini Gregory S. CFO Sell 50.0 -1,265 -0.69% ✗ $1.1K
Aug 11, 2025 Aug 13, 2025 Silver Ronald Principal Accounting Officer Sell 47.5 -2,846 -1.02% ✗ $2.4K
Jun 13, 2025 Jun 17, 2025 DENNER ALEXANDER J Director Neutral 55.0 +24,193 0.15% ✗ -
Jun 10, 2025 Jun 12, 2025 Kessler Marla L Director Neutral 90.0 +45,000 37.23% ✗ -
Jun 10, 2025 Jun 12, 2025 Shepard Jay Director Neutral 90.0 +45,000 35.56% ✗ -
Jun 10, 2025 Jun 12, 2025 Moukheibir Catherine Director Neutral 90.0 +45,000 61.69% ✗ -
Jun 10, 2025 Jun 12, 2025 Duane Jon R Director Neutral 90.0 +45,000 30.96% ✗ -
Jun 10, 2025 Jun 12, 2025 Currie Mark G Director Neutral 85.0 +45,000 7.92% ✗ -
Jun 10, 2025 Jun 12, 2025 McHugh Julie Director Neutral 90.0 +45,000 27.47% ✗ -
Jun 10, 2025 Jun 12, 2025 Dreyfus Andrew Director Neutral 90.0 +45,000 24.55% ✗ -
Jun 10, 2025 Jun 12, 2025 DENNER ALEXANDER J Director Neutral 60.0 +45,000 0.27% ✗ -
May 16, 2025 May 20, 2025 MCCOURT Thomas A CEO Sell 90.0 +526,647 45.38% ✗ $7.7K
May 16, 2025 May 20, 2025 Gaskins Tammi L Chief Commercial Officer Sell 47.5 -2,563 -1.05% ✗ $1.5K
Apr 2, 2025 Apr 4, 2025 DENNER ALEXANDER J Director Neutral 55.0 +10,416 0.06% ✗ -
Mar 21, 2025 Gaskins Tammi L Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Feb 10, 2025 Feb 12, 2025 MCCOURT Thomas A CEO Sell 42.5 -139,064 -10.70% ✗ $244.8K
Feb 10, 2025 Feb 12, 2025 Silver Ronald Principal Accounting Officer Sell 46.3 -12,048 -4.13% ✗ $21.2K
Feb 10, 2025 Feb 12, 2025 Shetzline Michael SVP, CMO, Head-Res&Drug Sell 95.0 +92,064 19.93% ✗ $72.6K
Feb 10, 2025 Feb 12, 2025 John Minardo Chief Legal Officer Sell 95.0 +83,284 25.64% ✗ $68.5K
Feb 10, 2025 Feb 12, 2025 Martini Gregory S. CFO Sell 46.3 -12,052 -6.15% ✗ $21.2K
Jan 27, 2025 Jan 29, 2025 Silver Ronald Principal Accounting Officer Neutral 90.0 +133,333 84.19% ✗ -
Jan 27, 2025 Jan 29, 2025 Martini Gregory S. CFO Neutral 90.0 +111,111 131.10% ✗ -
Jan 29, 2025 Martini Gregory S. CFO Neutral 52.5 - 0.00% ✗ -
Jan 17, 2025 Jan 22, 2025 Shetzline Michael SVP, CMO, Head-Res&Drug Neutral 90.0 +48,224 11.66% ✗ -
Jan 17, 2025 Jan 22, 2025 John Minardo Chief Legal Officer Neutral 90.0 +40,187 14.12% ✗ -
Jan 17, 2025 Jan 22, 2025 MCCOURT Thomas A CEO Neutral 90.0 +147,354 12.79% ✗ -
Dec 16, 2024 Dec 18, 2024 DENNER ALEXANDER J Director Neutral 47.5 +4,249 0.03% ✗ -
Nov 18, 2024 Nov 20, 2024 Davis Andrew SVP, Chief Business Officer Sell 46.3 -5,360 -1.85% ✗ $21.9K
Nov 18, 2024 Nov 20, 2024 Emany Sravan Kumar CFO Sell 46.3 -11,001 -3.43% ✗ $44.9K
Sep 16, 2024 Sep 18, 2024 DENNER ALEXANDER J Director Neutral 47.5 +3,282 0.02% ✗ -
Aug 12, 2024 Aug 14, 2024 John Minardo Chief Legal Officer Sell 46.3 -9,910 -3.36% ✗ $42.3K
Aug 12, 2024 Aug 14, 2024 Silver Ronald Principal Accounting Officer Sell 46.3 -3,107 -1.92% ✗ $13.3K
Jun 18, 2024 Jun 21, 2024 Shepard Jay Director Neutral 90.0 +24,311 23.78% ✗ -
Jun 18, 2024 Jun 21, 2024 Dreyfus Andrew Director Neutral 90.0 +24,311 14.83% ✗ -
Jun 18, 2024 Jun 21, 2024 Duane Jon R Director Neutral 90.0 +24,311 20.09% ✗ -
Jun 18, 2024 Jun 21, 2024 McHugh Julie Director Neutral 90.0 +24,311 17.42% ✗ -
Jun 18, 2024 Jun 21, 2024 Moukheibir Catherine Director Neutral 90.0 +24,311 49.99% ✗ -
Jun 18, 2024 Jun 21, 2024 Kessler Marla L Director Neutral 90.0 +24,311 25.17% ✗ -
Jun 18, 2024 Jun 21, 2024 DENNER ALEXANDER J Director Neutral 55.0 +24,311 0.15% ✗ -
Jun 18, 2024 Jun 21, 2024 Currie Mark G Director Neutral 82.5 +24,311 4.47% ✗ -
Jun 15, 2024 Jun 18, 2024 DENNER ALEXANDER J Director Neutral 47.5 +2,572 0.02% ✗ -
Jun 10, 2024 Jun 12, 2024 McHugh Julie Director Sell 25.0 -22,766 -14.03% ✓ $143.2K
Jun 6, 2024 Jun 10, 2024 Moukheibir Catherine Director Sell 20.0 -80,000 -62.19% ✗ $517.7K
May 20, 2024 May 22, 2024 MCCOURT Thomas A CEO Sell 40.0 -67,618 -5.55% ✗ $436.1K
May 20, 2024 May 22, 2024 Davis Andrew SVP, Chief Business Officer Sell 42.5 -22,725 -7.31% ✗ $146.6K
May 20, 2024 May 22, 2024 Shetzline Michael CMO,SVP,Head-Res&Drug Sell 42.5 -16,128 -3.75% ✗ $104K
May 20, 2024 May 22, 2024 John Minardo Chief Legal Officer Sell 42.5 -17,404 -5.58% ✗ $112.3K
May 16, 2024 May 20, 2024 Emany Sravan Kumar CFO Sell 42.5 -18,280 -5.39% ✗ $121.4K
Mar 15, 2024 Mar 19, 2024 DENNER ALEXANDER J Director Neutral 47.5 +1,662 0.01% ✗ -
Mar 8, 2024 Mar 12, 2024 John Minardo Chief Legal Officer Neutral 52.5 - 0.00% ✗ -
Mar 8, 2024 Mar 12, 2024 Emany Sravan Kumar CFO Neutral 52.5 - 0.00% ✗ -
Mar 8, 2024 Mar 12, 2024 Shetzline Michael CMO,SVP,Head-Res&Drug Neutral 52.5 - 0.00% ✗ -
Mar 8, 2024 Mar 12, 2024 Davis Andrew SVP, Chief Business Officer Neutral 52.5 - 0.00% ✗ -
Mar 8, 2024 Mar 12, 2024 MCCOURT Thomas A CEO Neutral 52.5 - 0.00% ✗ -
Mar 6, 2024 Mar 8, 2024 Duane Jon R Director Buy 90.0 +6,920 6.06% ✗ $60.2K
Mar 5, 2024 Mar 7, 2024 MCCOURT Thomas A CEO Neutral 90.0 +264,876 31.81% ✗ -
Mar 4, 2024 Mar 6, 2024 Emany Sravan Kumar CFO Buy 87.5 +10,684 3.67% ✗ $100.2K
Feb 12, 2024 Feb 14, 2024 John Minardo Chief Legal Officer Sell 90.0 +7,047 2.59% ✗ $722.1K
Feb 12, 2024 Feb 14, 2024 Shetzline Michael CMO,SVP,Head-Res&Drug Sell 90.0 +15,809 4.17% ✗ $588.5K
Feb 12, 2024 Feb 14, 2024 Silver Ronald Principal Accounting Officer Sell 95.0 +19,305 13.58% ✗ $120.5K
Feb 12, 2024 Feb 14, 2024 Davis Andrew SVP, Chief Business Officer Sell 95.0 +55,466 25.42% ✗ $150.1K
Feb 12, 2024 Feb 14, 2024 Emany Sravan Kumar CFO Neutral 90.0 +65,312 28.93% ✗ -
Feb 12, 2024 Feb 14, 2024 MCCOURT Thomas A CEO Sell 37.5 -177,164 -17.54% ✗ $2.7M
Feb 8, 2024 Feb 12, 2024 Emany Sravan Kumar CFO Sell 40.0 -41,332 -15.48% ✗ $615.8K
Jan 17, 2024 Jan 19, 2024 MCCOURT Thomas A CEO Neutral 90.0 +249,617 32.83% ✗ -
Jan 17, 2024 Jan 19, 2024 Shetzline Michael CMO,SVP,Head-Res&Drug Neutral 90.0 +57,971 18.05% ✗ -
Jan 17, 2024 Jan 19, 2024 John Minardo Chief Legal Officer Neutral 90.0 +79,981 41.61% ✗ -
Jan 17, 2024 Jan 19, 2024 Emany Sravan Kumar CFO Neutral 90.0 +85,000 46.69% ✗ -
Dec 15, 2023 Dec 19, 2023 DENNER ALEXANDER J Director Neutral 47.5 +1,347 0.01% ✗ -
Dec 15, 2023 Dec 19, 2023 Moukheibir Catherine Director Neutral 77.5 +1,572 1.24% ✗ -
Dec 14, 2023 Dec 18, 2023 Kessler Marla L Director Sell 28.8 -9,926 -9.32% ✓ $111.1K
Nov 20, 2023 Nov 22, 2023 Davis Andrew SVP, Chief Business Officer Sell 46.3 -3,287 -1.49% ✗ $31.9K
Nov 16, 2023 Nov 20, 2023 Emany Sravan Kumar CFO Sell 42.5 -6,661 -3.53% ✗ $62.9K
Sep 15, 2023 Sep 19, 2023 Moukheibir Catherine Director Neutral 77.5 +2,098 1.68% ✗ -
Sep 15, 2023 Sep 19, 2023 DENNER ALEXANDER J Director Neutral 47.5 +1,798 0.01% ✗ -
Sep 15, 2023 Sep 18, 2023 Emany Sravan Kumar CFO Buy 97.5 +36,072 23.63% ✗ $300.1K
Aug 29, 2023 Aug 31, 2023 Silver Ronald Principal Accounting Officer Neutral 85.0 +8,000 5.96% ✗ -
Aug 14, 2023 Aug 16, 2023 Silver Ronald Principal Accounting Officer Sell 46.3 -1,976 -1.45% ✗ $19.8K
Aug 14, 2023 Aug 16, 2023 John Minardo Chief Legal Officer Sell 42.5 -7,045 -3.54% ✗ $70.7K
Jun 20, 2023 Jun 22, 2023 Shepard Jay Director Neutral 90.0 +22,350 27.97% ✗ -
Jun 20, 2023 Jun 22, 2023 Moukheibir Catherine Director Neutral 90.0 +22,350 21.78% ✗ -
Jun 20, 2023 Jun 22, 2023 McHugh Julie Director Neutral 90.0 +22,350 15.97% ✗ -
Jun 20, 2023 Jun 22, 2023 Kessler Marla L Director Neutral 90.0 +22,350 26.56% ✗ -
Jun 20, 2023 Jun 22, 2023 Duane Jon R Director Neutral 90.0 +22,350 24.36% ✗ -
Jun 20, 2023 Jun 22, 2023 Dreyfus Andrew Director Neutral 90.0 +22,350 15.24% ✗ -
Jun 20, 2023 Jun 22, 2023 DENNER ALEXANDER J Director Neutral 55.0 +22,350 0.14% ✗ -
Jun 20, 2023 Jun 22, 2023 Currie Mark G Director Neutral 82.5 +22,350 4.28% ✗ -
Jun 15, 2023 Jun 20, 2023 Moukheibir Catherine Director Neutral 77.5 +1,586 1.57% ✗ -